The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Prevalence of sarcopenia in patients with chronic kidney disease: a global systematic review and meta‐analysis
Open accessAbstract
Sarcopenia is a risk factor for adverse clinical outcomes in chronic kidney disease (CKD) patients, including mortality. Diagnosis depends on adopted consensus definition and cutoff values; thus, prevalence rates are generally heterogeneous. We conducted a systematic review and meta‐analysis to investigate the global prevalence of sarcopenia and its traits across the wide spectrum of CKD. A systematic search was conducted using databases, including MEDLINE and EMBASE, for observational studies reporting the prevalence of sarcopenia. We considered sarcopenia according to the consensus definition of the European Working Group on Sarcopenia in Older People (EWGSOP), the Asian Working Group for Sarcopenia, the Foundation for the National Institutes of Health Sarcopenia Project, and the International Working Group on Sarcopenia (IWGS). Subgroup analyses by CKD stages, consensus, and gender were performed. Pooled prevalence was obtained from random‐effect models. A total of 140 studies (42 041 patients) across 25 countries were included in this systematic review and meta‐analyses. Global prevalence of sarcopenia was 24.5% [95% confidence interval (CI): 20.9–28.3) and did not differ among stages (P = 0.33). Prevalence varied according to the consensus definition from 11% to 30%, with no significant difference (P = 0.42). Prevalence of severe sarcopenia was 21.0% (95% CI: 11.7–32.0), with higher rates for patients on dialysis (26.2%, 95% CI: 16.6–37.1) compared to non‐dialysis (3.0%, 95% CI: 0–11.1; P < 0.01). Sarcopenic obesity was observed in 10.8% (95% CI: 3.5–21.2). Regarding sarcopenia traits, low muscle strength was found in 43.4% (95%CI: 35.0–51.9), low muscle mass in 29.1% (95% CI: 23.9–34.5), and low physical performance in 38.6 (95% CI: 30.9–46.6) for overall CKD. Prevalence was only higher in patients on dialysis (50.0%, 95% CI: 41.7–57.4) compared to non‐dialysis (19.6%, 95% CI: 12.8–27.3; P < 0.01) for low muscle strength. We found a high global prevalence of sarcopenia in the wide spectrum of CKD. Low muscle strength, the primary sarcopenia trait, was found in almost half of the overall population with CKD. Patients on dialysis were more prevalent to low muscle strength and severe sarcopenia. Nephrology professionals should be aware of regularly assessing sarcopenia and its traits in patients with CKD, especially those on dialysis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818 · cited 4×
“9 The results comparing dialysis and non-dialysis groups showed a higher prevalence of low muscle strength in those on dialysis, while muscle mass and physical performance did not.”
BackgroundMethodInfluentialSarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601
Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment
Chen, L.-K., Woo, J., Assantachai, P., Auyeung, T.-W., Chou, M.-Y., Iijima, K., Jang, H. C., Kang, L., Kim, M., Kim, S., et al. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2019.12.012 · Cited by 7,070
Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia
Chen, L.-K., Liu, L.-K., Woo, J., Assantachai, P., Auyeung, T.-W., Bahyah, K. S., Chou, M.-Y., Chen, L.-Y., Hsu, P.-S., Krairit, O., et al. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.11.025 · Cited by 4,051 · cited 1×
“…fi nitions as the European Working Group on Sarcopenia in Older People (EWGSOP; EWGSOP2), 9,13 the International Working Group on Sarcopenia (IWGS), 14 the Asian Working Group for Sarcopenia (AWGS; AWGS 2019), 15,16 and the Foundation for the National Institutes of Health Sarcopenia project (FNIH).”
BackgroundSarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803
Fielding, R. A., Vellas, B., Evans, W. J., Bhasin, S., Morley, J. E., Newman, A. B., Abellan van Kan, G., Andrieu, S., Bauer, J., Breuille, D., et al. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.01.003 · Cited by 3,256
Munn, Z., Moola, S., Lisy, K., Riitano, D., & Tufanaru, C. (2015) · International Journal of Evidence-Based Healthcare · doi:10.1097/xeb.0000000000000054 · Cited by 3,131
Studenski, S. A., Peters, K. W., Alley, D. E., Cawthon, P. M., McLean, R. R., Harris, T. B., Ferrucci, L., Guralnik, J. M., Fragala, M. S., Kenny, A. M., et al. (2014) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glu010 · Cited by 2,545
Sarcopenia: origins and clinical relevance
Rosenberg, I. H. (1997) · The Journal of Nutrition · doi:10.1093/jn/127.5.990s · Cited by 2,399
Metaprop: a Stata command to perform meta-analysis of binomial data
Nyaga, V. N., Arbyn, M., & Aerts, M. (2014) · Archives of Public Health · doi:10.1186/2049-3258-72-39 · Cited by 2,139
Research works printed but not linked: 23
- 10.1016/S0140-6736(19)31138-9 · DOI · Paper page
- 10.1016/j.clnu.2022.03.025 · DOI · Paper page
- 10.1002/jcsm.12890 · DOI · Paper page
- 10.1038/s41581-021-00498-0 · DOI · Paper page
- 10.1007/s40620-020-00840-y · DOI · Paper page
- 10.1007/s00223-021-00898-1 · DOI
- 10.1002/jcsm.13130 · DOI
- 10.1001/jama.283.15.2008 · DOI · Paper page
- 10.1002/sim.1186 · DOI · Paper page
- 10.1136/bmj.315.7109.629 · DOI · Paper page
- 10.1093/ndt/gfy252 · DOI
- 10.1002/jcsm.12705 · DOI · Paper page
- 10.1155/2022/1327332 · DOI
- 10.1093/ckj/sfac046 · DOI
- 10.3390/nu14194077 · DOI
- 10.1002/oby.23512 · DOI
- 10.1186/s12882-018-1055-6 · DOI
- 10.2215/CJN.10261013 · DOI · Paper page
- 10.1248/bpb.b19-00513 · DOI
- 10.1093/ajcn/85.3.695 · DOI · Paper page
- 10.1093/ndt/gft070 · DOI · Paper page
- 10.1002/ncp.10819 · DOI
- 10.1002/jcsm.12791 · DOI
Cited by
Sayer, A. A., Cooper, R., Arai, H., Cawthon, P. M., Ntsama Essomba, M.-J., Fielding, R. A., Grounds, M. D., Witham, M. D., & Cruz-Jentoft, A. J. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00550-w · Cited by 380
Impact of GLP-1 Receptor Agonist Therapy in Patients High Risk for Sarcopenia
Memel, Z., Gold, S. L., Pearlman, M., Muratore, A., & Martindale, R. (2025) · Current Nutrition Reports · doi:10.1007/s13668-025-00649-w · Cited by 63
Zhao, R., Dong, Y., Zheng, Q., & Yao, J. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1685014 · Cited by 16
Brunese, M. C., Femminella, G. D., Bencivenga, L., Tafuri, F., Caiazzo, C., Rengo, G., Guerra, G., & Komici, K. (2025) · GeroScience · doi:10.1007/s11357-025-01801-8 · Cited by 4
“Low muscle strength is found in approximately 43% of patients with chronic kidney disease [49]; muscle ultrasound has been suggested as a valuable method for identifying sarcopenia in patients with CKD [50].”
Metadata
- Authors
- Duarte, M. P., Almeida, L. S., Neri, S. G. R., Oliveira, J. S., Wilkinson, T. J., Ribeiro, H. S., & Lima, R. M.
- Venue
- Journal of Cachexia, Sarcopenia and Muscle
- Publisher
- Wiley
- Published
- 2024-01-24
- Volume
- 15
- Issue
- 2
- Pages
- 501-512
- ISSN
- 2190-5991 (ISSN-L)
- 2190-6009
- OpenAlex
- W4391173159
- Cited by
- 243
- References
- 17
- FWCI
- 18.62
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação de Apoio à Pesquisa do Distrito Federal (00193‐00001833/2023‐36)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence of sarcopenia in patients with chronic kidney disease: a global systematic review and meta‐analysis. https://app.cochat.ai/papers/10.1002/jcsm.13425
- The paper
- Duarte, M. P., Almeida, L. S., Neri, S. G. R., Oliveira, J. S., Wilkinson, T. J., Ribeiro, H. S., & Lima, R. M. (2024). Prevalence of sarcopenia in patients with chronic kidney disease: a global systematic review and meta‐analysis. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.13425
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.